Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veracyte

28.95
+0.48001.69%
Post-market: 28.75-0.2000-0.69%16:23 EDT
Volume:1.31M
Turnover:37.36M
Market Cap:2.26B
PE:93.39
High:29.43
Open:27.64
Low:27.50
Close:28.47
Loading ...

Stock Track | Veracyte Soars 8.5% on Strong Q3 Earnings, Bullish Analyst Outlook

Stock Track
·
07 Nov 2024

Stock Track | Veracyte Soars in Pre-Market on Strong Q3 Results and Bullish Analyst Outlook

Stock Track
·
07 Nov 2024

Veracyte price target raised to $46 from $43 at UBS

TIPRANKS
·
07 Nov 2024

Veracyte’s Strong Financial Performance and Growth Potential Lead to Buy Rating and Increased Price Target

TIPRANKS
·
07 Nov 2024

Veracyte Inc reports results for the quarter ended in January 1 - Earnings Summary

Reuters
·
07 Nov 2024

Veracyte Inc. Reports Strong Q3 2024 Growth

TIPRANKS
·
07 Nov 2024

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

Zacks
·
07 Nov 2024

Veracyte: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

Veracyte reports Q3 adjusted EPS 33c, consensus 3c

TIPRANKS
·
07 Nov 2024

Veracyte raises FY24 revenue view to $442M-$445M from $432M-$438M

TIPRANKS
·
07 Nov 2024

Veracyte Q3 2024 Adj. EPS $0.33 Beats $0.03 Estimate, Sales $115.860M Beat $109.812M Estimate

Benzinga
·
07 Nov 2024

BRIEF-Veracyte Q3 Revenue USD 115.9 Million Vs. IBES Estimate USD 109.8 Million

Reuters
·
07 Nov 2024

Veracyte Inc: Cash, Cash Equivalents & Short-Term Investments at End of Year to Be $280 Mln to $285 Mln

THOMSON REUTERS
·
07 Nov 2024

Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?

Zacks
·
30 Oct 2024

Top Analyst Reports for SAP, Goldman Sachs & Lockheed Martin

Zacks
·
24 Oct 2024

Veracyte price target raised to $40 from $35 at Leerink

TIPRANKS
·
17 Oct 2024

Veracyte Initiated at Buy by UBS

Dow Jones
·
16 Oct 2024

UBS Initiates Veracyte at Buy With $43 Price Target

MT Newswires Live
·
16 Oct 2024

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Zacks
·
11 Oct 2024

EXAS Gains FDA Nod for Cologuard Plus, Progresses With CRC Screening

Zacks
·
10 Oct 2024